Cargando…
Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
Risk of hepatitis B virus reactivation (HBVr) in patients with resolved HBV infection receiving immunosuppressive therapy has been a growing concern, particularly in the era of biological and targeted therapies. HBV monitoring versus antiviral prophylaxis against HBVr in those patients remains contr...
Autores principales: | Elsebaey, Mohamed A., Elbedewy, Tamer A., Elashry, Heba, Elrefaey, Waleed, Elshweikh, Samah A., Elhadidy, Ahmed A., Shalaby, Neveen A., Elsokkary, Assem Mohamed, Elashtokhy, Hossam Eldin A., Abo-Amer, Yousry Esam-Eldin, Abo-Elfetoh, Ashraf Rafat, Hassanien, Sharaf Elsayed Ali, Fouad, Amina, Abdellatif, Raghda Samir, Ismail, Amro Abdelaziz Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704936/ https://www.ncbi.nlm.nih.gov/pubmed/36451458 http://dx.doi.org/10.1097/MD.0000000000031962 |
Ejemplares similares
-
Predictors of in-hospital mortality in a cohort of elderly Egyptian patients with acute upper gastrointestinal bleeding
por: Elsebaey, Mohamed A., et al.
Publicado: (2018) -
Predictors for eltrombopag response in patients with hepatitis C virus-associated thrombocytopenia
por: Elbedewy, Tamer A, et al.
Publicado: (2019) -
Intermittent versus Daily Eltrombopag Dosage Protocols for the Treatment of Primary Immune Thrombocytopenia: Real-Life Experience
por: Elbedewy, Tamer A, et al.
Publicado: (2020) -
Declining prevalence of hepatitis C virus among university students in one of the main governorates in Egypt
por: Abo-Amer, Yousry Esam-Eldin, et al.
Publicado: (2018) -
Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease: A real-life experience
por: Abd-Elsalam, Sherief, et al.
Publicado: (2020)